Vivalink, a provider of digital healthcare solutions, today announced the commercial release of its new wearable ECG sensor adhesive that improves the detection of p-waves during ambulatory cardiac monitoring.
P-wave abnormalities are strong predictors of future adverse cardiac events, including atrial fibrillation, ischemic stroke, and even sudden cardiac death.
As a newly introduced companion to Vivalink's rechargeable, re-usable multi-vital ECG patch, the adhesive is an enhancement to Vivalink's wearable monitors, supporting earlier intervention, improved patient outcomes, and high-quality data collection in clinical trials.
Key features of the upgraded adhesive include:
- Modified Lead 1 placement to enhance p-wave visibility
- Single use, seven day wear time with water resistance
- Contoured design for maximum flexibility of movement
- Optimized for both comfort and data integrity
- Validated for use in remote and in-person clinical trial settings
Worn vertically on the center chest above the sternum, the adhesive increases p-wave signal detection by up to 160%. P-waves, which represent the electrical activity of the heart's upper chambers, are important markers of atrial health. Subtle changes in their shape or size can be early indicators of atrial disease, making clear signal capture vital for clinical decision-making in arrhythmias and atrial fibrillation risk, and strengthens the reliability of trial data.
The design of the adhesive leverages Vivalink's patented eSkin technology for user comfort and flexibility.
Vivalink's multi-vital ECG patch is a lightweight, wearable cardiac monitor built for continuous ECG monitoring in clinical care, remote patient monitoring and clinical research environments. Reusable and chargeable, the patch streams live ECG and vital signs such as heart rate, respiratory rate, and skin temperature while also storing data locally to prevent gaps in the event of a network disruption.
